Literature DB >> 21576955

Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score.

Arnold P Oranje1.   

Abstract

The SCORAD (Index) is the best validated scoring system in atopic dermatitis (AD). Modification of the SCORAD Index has led several times to incorrect use of the system. To measure the extent of AD, the rule of nines is applied on a front/back drawing of the patient's inflammatory lesions. The extent can be graded from 0 to 100. The intensity part of the SCORAD consists of 6 items: erythema, oedema/papulation, excoriations, lichenification, oozing/crusts and dryness. Each item can be graded on a scale from 0 to 3. The subjective items include daily pruritus and sleeplessness. The SCORAD Index formula is: A/5 + 7B/2 + C. In this formula A is defined as the extent (0-100), B is defined as the intensity (0-18) and C is defined as the subjective symptoms (0-20). The maximal score of the SCORAD Index is 103. The objective SCORAD consist of the extent and the intensity items; the formula is A/5 + 7B/2. The maximal objective SCORAD score is 83 (with 10 additional points for severe disfiguring eczema of the face and hands). Patients should also evaluate their dermatitis, because their well-being is the most important aspect of treating AD. Therefore different self-assessment scores for AD patients, including the patient-oriented SCORAD, were developed. The patient-oriented SCORAD correlates well with the SCORAD Index. The Three-Item Severity (TIS) score involves the scoring of erythema (redness), oedema and excoriations (scratches) in one representative lesion. The TIS score corresponds well with the objective SCORAD and can be used as prescreening system or as a quick system in studies and is excellent for epidemiological studies.
Copyright © 041_ S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21576955     DOI: 10.1159/000323308

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  26 in total

Review 1.  Sublingual immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system.

Authors:  Samantha R Gendelman; David M Lang
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806

2.  Docosahexaenoic Acid Effect on Prenatal Exposure to Arsenic and Atopic Dermatitis in Mexican Preschoolers.

Authors:  Ivan Figueroa-Garduño; Consuelo Escamilla-Núñez; Albino Barraza-Villarreal; Leticia Hernández-Cadena; Erika Noelia Onofre-Pardo; Isabelle Romieu
Journal:  Biol Trace Elem Res       Date:  2022-09-08       Impact factor: 4.081

3.  Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.

Authors:  Danielle Rogner; Tilo Biedermann; Felix Lauffer
Journal:  Acta Derm Venereol       Date:  2022-03-22       Impact factor: 3.875

4.  Measurement properties of three assessments of burden used in atopic dermatitis in adults.

Authors:  K R Patel; V Singam; P P Vakharia; R Chopra; R Sacotte; N Patel; S Immaneni; R Kantor; D Y Hsu; J I Silverberg
Journal:  Br J Dermatol       Date:  2018-11-12       Impact factor: 9.302

5.  Combined treatment of Taraxaci Herba and R7050 alleviates the symptoms of herpes simplex virus-induced Behçet's disease in rats.

Authors:  Myeounghoon Cha; Minjee Kwon; Misun Park; Jin-Hwan Oh; Kang-Keyng Sung; Bae Hwan Lee
Journal:  Integr Med Res       Date:  2021-02-17

6.  Atopic dermatitis and the atopic march: what is new?

Authors:  Annalisa Patrizi; Alessandro Pileri; Federica Bellini; Beatrice Raone; Iria Neri; Giampaolo Ricci
Journal:  J Allergy (Cairo)       Date:  2011-09-13

7.  Evaluation of a Pseudoceramide Moisturizer in Patients with Mild-to-Moderate Atopic Dermatitis.

Authors:  Amelie Clementine Seghers; Sophie Chan Cai; Madeleine Sheun Ling Ho; Yoke Chin Giam; Lucinda Tan; Carina Marie Grönhagen; Mark Boon Yang Tang
Journal:  Dermatol Ther (Heidelb)       Date:  2014-03-12

8.  Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin.

Authors:  Taras Lyubchenko; Hannah K Collins; Elena Goleva; Donald Y M Leung
Journal:  Ann Allergy Asthma Immunol       Date:  2020-09-05       Impact factor: 6.347

9.  Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis.

Authors:  Lam C Tsoi; Elke Rodriguez; Frauke Degenhardt; Hansjörg Baurecht; Ulrike Wehkamp; Natalie Volks; Silke Szymczak; William R Swindell; Mrinal K Sarkar; Kalpana Raja; Shuai Shao; Matthew Patrick; Yilin Gao; Ranjitha Uppala; Bethany E Perez White; Spiro Getsios; Paul W Harms; Emanual Maverakis; James T Elder; Andre Franke; Johann E Gudjonsson; Stephan Weidinger
Journal:  J Invest Dermatol       Date:  2019-01-11       Impact factor: 7.590

10.  Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.

Authors:  Béatrice Gleize; Franck Tourniaire; Laurence Depezay; Romain Bott; Marion Nowicki; Lionel Albino; Denis Lairon; Emmanuelle Kesse-Guyot; Pilar Galan; Serge Hercberg; Patrick Borel
Journal:  Br J Nutr       Date:  2012-12-11       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.